Former Sanofi Pasteur head Pisano to take VaxInnate helm
This article was originally published in Scrip
Executive Summary
Wayne Pisano, who retired as president and CEO of Sanofi Pasteur last year, has been appointed president and CEO of VaxInnate, replacing Dr Thomas Hofstaetter who retired at the end of 2011 after two years in post. Cranbury, New Jersey-based VaxInnate has a BARDA contract to develop influenza vaccines.